Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

Auteurs

C.A. Bellera, N. Penel, M. Ouali, S. Bonvalot, P.G. Casali, O.S. Nielsen, M. Delannes, S. Litière, F. Bonnetain, T.S. Dabakuyo, R.S. Benjamin, J.-Y. Blay, B.N. Bui, F. Collin, T.F. Delaney, F. Duffaud, T. Filleron, M. Fiore, H. Gelderblom, S. George, R. Grimer, P. Grosclaude, A. Gronchi, R. Haas, P. Hohenberger, R. Issels, A. Italiano, V. Jooste, A. Krarup-Hansen, C. Le Péchoux, C. Mussi, O. Oberlin, S. Patel, S. Piperno-Neumann, C. Raut, I. Ray-Coquard, P. Rutkowski, S. Schuetze, S. Sleijfer, E. Stoeckle, M. Van Glabbeke, P. Woll, S. Gourgou-Bourgade, S. Mathoulin-Pélissier